Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Let's think something different here......
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(31)
•••
Comment by Smiles62on Jun 06, 2020 6:54pm
111 Views
Post# 31120719

RE:RE:RE:RE:RE:RE:RE:RE:Let's think something different here......

RE:RE:RE:RE:RE:RE:RE:RE:Let's think something different here......
you are correct about phase1 process, but the problem is before even thinking of conducting phase 1 trial, the rule is you need to have 10 patients!!! The last NR is clear about that, and it certainly does not give hope to that effect. It's obvious that has learned a lesson, he does'nt even respond to calls or emails anymore! And if you ask Chad, he will certainly not shoot himself in the foot, he just got a good paying job. Remember when some here pushed the video about guy shooting himself with our miracle thing, did he ever report his findings??? Maybe a few got those results, maybe that coincides with the stock moving on a steady decline from 0.20 to 0.05??? And the most amateur move was to try to recruit in Montana, what!!!!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities